Geron's Golden Parachute for Okarma
Tom Okarma may be out as Geron's CEO but he has a nifty cushion to ease the pain.
Reporter Ron Leuty of the San Francisco Business Times has reported that the onetime head of the Menlo Park stem cell firm could receive up to $1.3 million, including $802,500 in severance pay, as part of an agreement with the firm.
The package consists of consulting fees,…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.